Literature DB >> 27770172

Focus on acute circulatory failure.

Jan Bakker1,2,3.   

Abstract

Entities:  

Year:  2016        PMID： 27770172     DOI： 10.1007/s00134-016-4596-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  20 in total

1.  Understanding clinical signs of poor tissue perfusion during septic shock.

Authors:  Hafid Ait-Oufella; Jan Bakker
Journal:  Intensive Care Med       Date:  2016-02-04       Impact factor: 17.440

2.  Effects of fluid administration on arterial load in septic shock patients.

Authors:  Manuel Ignacio Monge García; Pedro Guijo González; Manuel Gracia Romero; Anselmo Gil Cano; Chris Oscier; Andrew Rhodes; Robert Michael Grounds; Maurizio Cecconi
Journal:  Intensive Care Med       Date:  2015-06-11       Impact factor: 17.440

3.  Early peripheral perfusion-guided fluid therapy in patients with septic shock.

Authors:  Michel E van Genderen; Noel Engels; Ralf J P van der Valk; Alexandre Lima; Eva Klijn; Jan Bakker; Jasper van Bommel
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

4.  Early lactate clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials.

Authors:  Wan-Jie Gu; Zhongheng Zhang; Jan Bakker
Journal:  Intensive Care Med       Date:  2015-07-08       Impact factor: 17.440

5.  Capillary refill time exploration during septic shock.

Authors:  H Ait-Oufella; N Bige; P Y Boelle; C Pichereau; M Alves; R Bertinchamp; J L Baudel; A Galbois; E Maury; B Guidet
Journal:  Intensive Care Med       Date:  2014-05-09       Impact factor: 17.440

6.  Changes in peripheral perfusion relate to visceral organ perfusion in early septic shock: A pilot study.

Authors:  Andreas Brunauer; Andreas Koköfer; Otgon Bataar; Ilse Gradwohl-Matis; Daniel Dankl; Jan Bakker; Martin W Dünser
Journal:  J Crit Care       Date:  2016-05-12       Impact factor: 3.425

Review 7.  A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators.

Authors:  D C Angus; A E Barnato; D Bell; R Bellomo; C-R Chong; T J Coats; A Davies; A Delaney; D A Harrison; A Holdgate; B Howe; D T Huang; T Iwashyna; J A Kellum; S L Peake; F Pike; M C Reade; K M Rowan; M Singer; S A R Webb; L A Weissfeld; D M Yealy; J D Young
Journal:  Intensive Care Med       Date:  2015-05-08       Impact factor: 17.440

8.  Combination of arterial lactate levels and venous-arterial CO2 to arterial-venous O 2 content difference ratio as markers of resuscitation in patients with septic shock.

Authors:  Gustavo A Ospina-Tascón; Mauricio Umaña; William Bermúdez; Diego F Bautista-Rincón; Glenn Hernandez; Alejandro Bruhn; Marcela Granados; Blanca Salazar; César Arango-Dávila; Daniel De Backer
Journal:  Intensive Care Med       Date:  2015-03-20       Impact factor: 17.440

9.  Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine.

Authors:  Maurizio Cecconi; Daniel De Backer; Massimo Antonelli; Richard Beale; Jan Bakker; Christoph Hofer; Roman Jaeschke; Alexandre Mebazaa; Michael R Pinsky; Jean Louis Teboul; Jean Louis Vincent; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2014-11-13       Impact factor: 17.440

10.  Effects of passive leg raising and volume expansion on mean systemic pressure and venous return in shock in humans.

Authors:  Laurent Guérin; Jean-Louis Teboul; Romain Persichini; Martin Dres; Christian Richard; Xavier Monnet
Journal:  Crit Care       Date:  2015-11-23       Impact factor: 9.097
View more
  1 in total

1.  Right-left ventricular interdependence: a promising predictor of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock.

Authors:  Nadia Aissaoui; Julia Caudron; Pascal Leprince; Jean-Yves Fagon; Guillaume Lebreton; Alain Combes; Benoit Diebold
Journal:  Intensive Care Med       Date:  2016-12-23       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.